Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

India Globalization Capital Inc (IGC)

India Globalization Capital Inc (IGC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,974
  • Shares Outstanding, K 51,054
  • Annual Sales, $ 900 K
  • Annual Income, $ -8,810 K
  • 60-Month Beta 3.05
  • Price/Sales 61.32
  • Price/Cash Flow N/A
  • Price/Book 0.81
Trade IGC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.25
  • Most Recent Earnings -0.05 on 02/10/22
  • Next Earnings Date 06/13/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 589.50% ( +57.35%)
  • Historical Volatility 80.69%
  • IV Percentile 97%
  • IV Rank 40.99%
  • IV High 1,363.62% on 05/18/22
  • IV Low 51.70% on 12/17/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 189
  • Volume Avg (30-Day) 58
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 12,374
  • Open Int (30-Day) 17,135

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4220 +6.64%
on 05/12/22
0.7999 -43.74%
on 04/25/22
-0.3442 (-43.34%)
since 04/22/22
3-Month
0.4220 +6.64%
on 05/12/22
1.1600 -61.21%
on 03/25/22
-0.5276 (-53.97%)
since 02/23/22
52-Week
0.4220 +6.64%
on 05/12/22
4.6500 -90.32%
on 07/22/21
-0.9600 (-68.09%)
since 05/21/21

Most Recent Stories

More News
India Globalization Capital, Inc. (IGC) Announces Final Approval of Settlement of Shareholder Class Action Lawsuits

India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announces today that on April 13, 2022, the United States District Court for the District of Maryland entered an Order granting...

IGC : 0.4500 (-2.41%)
India Globalization Capital Appoints Claudia Grimaldi to its Board of Directors

India Globalization Capital, Inc. (NYSE American: IGC) announces that the Board has appointed Ms. Claudia Grimaldi as a non-independent Director, effective March 23, 2022. IGC now has 5 directors including...

IGC : 0.4500 (-2.41%)
IGC Reports Financial Results for the December 31, 2021 Quarter

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ending December 31, 2021 – quarter three of the Company’s 2022 fiscal year.

IGC : 0.4500 (-2.41%)
India Globalization Capital Appoints Former Congressman Jim Moran to Its Board of Directors

India Globalization Capital, Inc. (NYSE American: IGC) is excited to announce that the Board has appointed former Congressman Jim Moran (“Congressman Moran”) as an independent Director. IGC is delighted...

IGC : 0.4500 (-2.41%)
Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

(NYSE American: IGC), India Globalization Capital, Inc. (“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary...

IGC : 0.4500 (-2.41%)
Phase 1 Clinical Trial Provides Valuable Insights on Safe and Effective Dosing of IGC-AD1 for Alzheimer’s Patients

(NYSE American: IGC), India Globalization Capital, Inc. (IGC) today announces preliminary results for its exploratory endpoints from its Phase 1 IGC-AD1 clinical trial. IGC-AD1 is a proprietary cannabis-based...

IGC : 0.4500 (-2.41%)
Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

(NYSE American: IGC), India Globalization Capital, Inc. (IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The investigational new...

IGC : 0.4500 (-2.41%)
IGC Reports Financial Results for the September 30, 2021 Quarter

India Globalization Capital, Inc. (NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year.

IGC : 0.4500 (-2.41%)
IGC Announces Results of its 2021 Annual Stockholders Meeting

India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces that during its Annual Meeting of Shareholders scheduled for and convened on October 15, 2021, voting on all matters as disclosed on the...

IGC : 0.4500 (-2.41%)
Pre-Market Brief: U.S. Stocks Set to Open Weaker

Morning Markets Sep S&P 500 futures this morning are down -0.13%. Stock futures are moving lower today on negative carry-over from a slide in European stocks on concern the ECB is getting ready to slow...

FTFT : 0.4469 (-5.34%)
MARA : 9.93 (+1.64%)
BTBT : 1.6200 (-2.41%)
COIN : 66.10 (-0.08%)
RIOT : 6.86 (+0.29%)
ADI : 161.55 (-0.55%)
ALB : 242.94 (+2.75%)
CTXS : 99.78 (+0.51%)
MCFE : 25.99 (-0.04%)
IGC : 0.4500 (-2.41%)
BMBL : 27.54 (-2.24%)
PHM : 42.43 (-0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company's patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate...

See More

Key Turning Points

3rd Resistance Point 0.5013
2nd Resistance Point 0.4862
1st Resistance Point 0.4681
Last Price 0.4500
1st Support Level 0.4349
2nd Support Level 0.4198
3rd Support Level 0.4017

See More

52-Week High 4.6500
Fibonacci 61.8% 3.0349
Fibonacci 50% 2.5360
Fibonacci 38.2% 2.0371
Last Price 0.4500
52-Week Low 0.4220

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar